Cargando…
Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
OBJECTIVES: Inhaled corticosteroids (ICS) reduce exacerbation rates and the decline in lung function in people with chronic obstructive pulmonary disease (COPD). There is evidence that smoking causes ‘steroid resistance’ and thus reduces the effect of ICS. This systematic review aimed to investigate...
Autores principales: | Sonnex, Kimberley, Alleemudder, Hanna, Knaggs, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245617/ https://www.ncbi.nlm.nih.gov/pubmed/32300001 http://dx.doi.org/10.1136/bmjopen-2020-037509 |
Ejemplares similares
-
Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016) -
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013) -
Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease – a cohort study using sequence analysis (PICCS)
por: Klitgaard, Allan, et al.
Publicado: (2023) -
Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020) -
Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2019)